drugset / Trial / NCT01832129

Vitamin B12 Acceptance and Biomarker Response Study

NCT01832129

RandomizedParallel-groupOpen-labelTreatment

Summary

In this study, biomarker response after supplementation with oral and intramuscular vitamin B12 will be compared in a randomized clinical trial. Electronic compliance monitoring will be used to control for non compliance as a possible confounder in oral treatment. Additionally subjective acceptance in terms of presumed preferences will be compared with oral vs. intramuscular supplementation of vitamin B12 in the view of the patient.

Timeline

Start
2013-05
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydroxocobalamin Unknown 1 mg Intramuscular
Subject Vitamin B12 Other / unclassified 1 mg Oral